HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women Study.

AbstractBACKGROUND AND PURPOSE:
Abnormalities in endogenous fibrinolysis are associated with an increased risk for stroke in men and older adults. We tested the hypothesis that elevated plasma tissue plasminogen activator (tPA) antigen, a marker for impaired endogenous fibrinolysis, is an independent risk factor for stroke in young women.
METHODS:
Subjects were 59 nondiabetic females ages 15 to 44 years with cerebral infarction from the Baltimore-Washington area and 97 control subjects frequency-matched for age who were recruited by random-digit dialing from the same geographic area. A history of cerebrovascular disease risk factors was obtained by face-to-face interview. Plasma tPA antigen was measured by enzyme-linked immunosorbent assay.
RESULTS:
Mean plasma tPA antigen levels were significantly higher in stroke patients than control subjects (4. 80+/-4.18 versus 3.23+/-3.67 ng/mL; P=0.015). After adjustment for age, hypertension, cigarette smoking, body mass index, and ischemic heart disease, there was a dose-response association between tPA antigen and stroke with a 3.9-fold odds ratio of stroke (95% CI, 1.2 to 12.4; P=0.03) for the upper quartile (>4.9 ng/mL) of tPA antigen compared with the lowest quartile. The dose-response relationship between tPA antigen and stroke was equally present in white and nonwhite women, and further adjustment for total and HDL cholesterol levels only modestly attenuated this association.
CONCLUSIONS:
This population-based case-control study shows that elevated plasma tPA antigen level is independently associated with an increased risk for ischemic stroke in nondiabetic females 15 to 44 years of age. These findings support the hypothesis that impaired endogenous fibrinolysis is an important risk factor for stroke in young women.
AuthorsR F Macko, S J Kittner, A Epstein, D K Cox, M A Wozniak, R J Wityk, B J Stern, M A Sloan, R Sherwin, T R Price, R J McCarter, C J Johnson, C J Earley, D W Buchholz, P D Stolley
JournalStroke (Stroke) Vol. 30 Issue 1 Pg. 7-11 (Jan 1999) ISSN: 0039-2499 [Print] United States
PMID9880380 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Plasminogen Activators
Topics
  • Adolescent
  • Adult
  • Cerebral Infarction (blood, epidemiology, prevention & control)
  • Cerebrovascular Disorders (blood, epidemiology, prevention & control)
  • Female
  • Fibrinolysis (physiology)
  • Humans
  • Plasminogen Activators (blood)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: